GLP-1 Dosing for Weight Loss

Last reviewed: May 14, 2026

Last updated: May 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

There is no universal answer to how many GLP-1 injections you need for weight loss—dosing is highly individualized based on your metabolic profile, starting weight, and tolerability. Clinical protocols typically begin with lower doses and escalate every 1-4 weeks until therapeutic response or side effects guide further adjustment.

PlexusDx focuses on precision wellness by helping you understand the biological factors that may influence your GLP-1 response. Genetic predispositions in appetite regulation and metabolic pathways can provide important context for conversations with your provider about optimal dosing and expectations.

How GLP-1 Dosing Protocols Work: From Initiation to Maintenance

GLP-1 therapies are not given as a fixed series of injections. Instead, treatment follows a titration schedule—gradual dose increases over weeks—to improve tolerability and allow your body to adapt. Standard protocols start at the lowest available dose and advance if well-tolerated.

For semaglutide, typical initiation is 0.25 mg weekly, escalating to 0.5 mg, then 1.0 mg, 1.7 mg, and 2.4 mg over 4-16 weeks depending on provider guidance and your response. Tirzepatide follows a similar pattern, starting at 2.5 mg and advancing to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg based on tolerability and clinical goals.

Factors That Influence Your Personal GLP-1 Response and Dosing Needs

Your optimal GLP-1 dose depends on several interconnected biological and lifestyle factors. These include your baseline weight, metabolic rate, insulin sensitivity, stomach function, and genetic variations in GLP-1 receptor expression. No two patients will require identical protocols.

Clinical evidence shows that approximately 70-80% of patients achieve clinically meaningful weight loss with GLP-1 therapy, but the dose at which this occurs varies widely. Some patients respond to lower maintenance doses, while others require higher therapeutic doses to achieve target weight loss.

Factor	Impact on GLP-1 Dosing
Starting BMI or weight	Higher baseline weight may require higher maintenance doses or longer titration periods to achieve target response
GLP1R genetic variants	Predispositions in GLP1R rs6923761 may influence receptor sensitivity and optimal dose titration patterns
Gastrointestinal function	Slower gastric emptying or baseline GI sensitivity may require slower dose escalation and lower maintenance targets
Concurrent medications	Certain medications affecting appetite or glucose metabolism may interact with GLP-1 effects and influence dosing decisions
Previous medication responses	History of tolerance to appetite-suppressing agents or metabolic medications can inform starting dose and escalation pace

Managing Side Effects to Find Your Therapeutic Dose

Nausea, vomiting, constipation, and loss of appetite are common during titration. Importantly, these side effects often guide dosing decisions—if they become intolerable, your provider may pause or slow dose escalation, or recommend a lower maintenance dose that still provides clinical benefit.

Most patients experience improvement in gastrointestinal side effects within 1-2 weeks of dose stabilization. If side effects persist beyond 2-3 weeks at a given dose, this signals that your body may tolerate a lower therapeutic dose better. This is not treatment failure—it is clinical information that informs your personalized protocol.

Who Should Start GLP-1 Therapy and How Provider Evaluation Guides Dosing

GLP-1 therapy is appropriate for adults with obesity (BMI ≥ 30) or overweight (BMI 27-29.9) with weight-related comorbidities, particularly those with type 2 diabetes or cardiovascular risk factors. Your provider will evaluate baseline kidney function, blood pressure, medication interactions, and personal/family history before dosing recommendations.

Before starting, your provider should review your complete medical history, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia (MEN2), as these are contraindications to GLP-1 therapy. Baseline assessment also informs starting dose selection and the pace of titration.

How PlexusDx Supports a More Personalized Approach

PlexusDx offers the Precision Peptide Genetic Test, which assesses predispositions in key GLP-1 and metabolic pathways including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. This information may help provide context about your genetic predisposition to appetite regulation patterns and metabolic response, supporting more informed conversations with your provider about dosing strategy.

The Precision Peptide Genetic Test reveals inherent predispositions in peptide receptor sensitivity and metabolic pathways—not your guaranteed medication response or exact dose outcome. Genetic variants influence how your body's appetite-regulation systems function at baseline; this should be interpreted with a qualified healthcare provider who integrates genetic context with your clinical history, current weight, and tolerability data.

Understanding your genetic predispositions can support a more personalized dosing conversation with your provider. Rather than following a standard protocol blindly, you and your healthcare team can discuss whether your genetic profile suggests slower tolerance to escalation, potential for achieving goals at lower maintenance doses, or other individualized considerations that improve your treatment experience.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many weeks does a typical GLP-1 dosing schedule take from start to maintenance?

Most titration schedules span 4-16 weeks depending on the specific medication and how quickly your body tolerates dose increases. Standard practice advances every 1-4 weeks if side effects remain mild and weight loss is progressing.

Can I stay on a lower GLP-1 dose and still see weight loss results?

Yes. Clinical data shows that some patients achieve meaningful weight loss at lower doses (e.g., semaglutide 1.0 mg or tirzepatide 5-7.5 mg) if side effects are limiting or if clinical response is adequate at that level. Your provider determines the minimum effective dose for your goals.

How does PlexusDx help me understand my personal GLP-1 dosing needs?

The Precision Peptide Genetic Test ($99 add-on or $298 standalone) analyzes predispositions in GLP1R, GIPR, FTO, and MC4R variants. Combined with your clinical evaluation, this context can support conversations with your provider about optimal dosing and expected response patterns tailored to your biology.

What side effects signal I may need a lower maintenance dose?

Persistent nausea, vomiting, or severe appetite loss lasting beyond 2-3 weeks at a dose suggests your body may tolerate a lower target better. Discuss with your provider—reducing dose is not failure but a clinical adjustment for long-term adherence and safety.

Does my genetic profile predict exactly how high my GLP-1 dose will need to be?

Genetic predispositions inform general patterns in appetite regulation and metabolic function, but they do not predict your exact dose requirement. Clinical factors—starting weight, gastrointestinal tolerance, comorbidities, and observed response—ultimately guide your provider's dosing decisions.

How Many Ozempic Shots Do You Need to Lose Weight?